Mid-Term Outcomes of TAVR in Intermediate-Risk Patients: Potential Targets for Improvement

J Am Coll Cardiol. 2023 Jul 11;82(2):124-127. doi: 10.1016/j.jacc.2023.04.048.

Authors

Subodh Verma¹, Deepak L Bhatt², Gilbert H L Tang³

Affiliations

¹ Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: Subodh.Verma@unityhealth.to.
² Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: https://twitter.com/DLBhattMD.
³ Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: https://twitter.com/GilbertTangMD.

PMID: 37407111
DOI: 10.1016/j.jacc.2023.04.048

No abstract available

Keywords: durability; outcomes; surgical aortic valve replacement; transcatheter aortic valve replacement.

Publication types

Editorial
Comment

MeSH terms

Aortic Valve / surgery
Aortic Valve Stenosis* / surgery
Heart Valve Prosthesis Implantation*
Heart Valve Prosthesis*
Humans
Risk Factors
Transcatheter Aortic Valve Replacement*
Treatment Outcome